Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 19/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.44 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14971844 | 1.00 | DGAT1 (0.52) | DGAT1KCNH2ADORA2ASOAT1DHODH | |
| SCHEMBL14969212 | 1.00 | DGAT1 (0.52) | DGAT1KCNH2ADORA2ASOAT1DHODH | |
| SCHEMBL14969093 | 0.90 | DGAT1 (0.56) | DGAT1KCNH2ADORA2ASOAT1DHODH | |
| SCHEMBL14969139 | 0.90 | DGAT1 (0.56) | DGAT1KCNH2ADORA2ASOAT1DHODH | |
| SCHEMBL14971565 | 0.90 | DGAT1 (0.56) | DGAT1KCNH2ADORA2ASOAT1DHODH | |
| SCHEMBL14969148 | 0.90 | DGAT1 (0.53) | DGAT1KCNH2ADORA2ASOAT1 | |
| SCHEMBL14969147 | 0.90 | DGAT1 (0.53) | DGAT1KCNH2ADORA2ASOAT1 | |
| SCHEMBL14969285 | 0.90 | DGAT1 (0.53) | DGAT1KCNH2ADORA2ASOAT1 | |
| SCHEMBL14971870 | 0.89 | DGAT1 (0.46) | DGAT1KCNH2ADORA2ASOAT1 | |
| SCHEMBL14968362 | 0.89 | DGAT1 (0.44) | DGAT1KCNH2ADORA2ASOAT1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013074387-A1 | IMIDAZOLE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013074387-A1 | IMIDAZOLE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2013-05-23 | — | — | WO | disclosed |